Literature DB >> 32011153

Development and evaluation of a new short form of the Conformity to Masculine Norms Inventory (CMNI-30).

Ronald F Levant1, Ryon McDermott2, Mike C Parent3, Nuha Alshabani4, James R Mahalik5, Joseph H Hammer6.   

Abstract

The Conformity to Masculine Norms Inventory (CMNI) has been an important tool in researching masculinity. With the original measure at 94 items (Mahalik et al., 2003), there have been several abbreviated forms developed from 11 to 55 items. However, in confirmatory factor analyses (CFA's) testing 13 common factors, bifactor, hierarchical, and unidimensional models, only 4 models demonstrated adequate fit to the data, and most of these were for the still quite long 46-item version. As a result, there was no psychometrically strong truly short form of the CMNI. In the present study, data from 1561 community and university men were used to develop a short form. First an exploratory factor analysis using a portion of the data was conducted, which resulted in a 10-subscale dimensionality, followed by CFA estimating a common factors model. The results of the CFA were used to create two candidate models for a 30-item short form of the CMNI, based on Classical test theory (CTT) and optimized CTT. The best-fitting candidate model for the CMNI-30 was CTT. Next, the fit of the 29, 46, and 94 item models were compared to the 30-item version, which had the superior fit. Then, measurement invariance between White men and men of color was assessed, choosing this comparison because hegemonic masculinity is theorized to marginalize men of color. Evidence was found for full configural and metric, and partial scalar and residuals invariance. Finally, significant relationships between CMNI-30 scores and indicators of depression and anxiety provides preliminary concurrent evidence for its validity. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Year:  2020        PMID: 32011153     DOI: 10.1037/cou0000414

Source DB:  PubMed          Journal:  J Couns Psychol        ISSN: 0022-0167


  7 in total

Review 1.  The Operationalisation of Sex and Gender in Quantitative Health-Related Research: A Scoping Review.

Authors:  Sophie Horstmann; Corinna Schmechel; Kerstin Palm; Sabine Oertelt-Prigione; Gabriele Bolte
Journal:  Int J Environ Res Public Health       Date:  2022-06-18       Impact factor: 4.614

2.  Gender Norms, Discrimination, Acculturation, and Depressive Symptoms among Latino Men in a New Settlement State.

Authors:  Jennifer Toller Erausquin; Eunyoung Song; Scott D Rhodes
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

3.  What is the Image of the "Typical Cancer Patient"? The View of Physicians.

Authors:  Angeliki Tsiouris; Nadine Ungar; Martina Gabrian; Alexander Haussmann; Karen Steindorf; Joachim Wiskemann; Monika Sieverding
Journal:  Am J Mens Health       Date:  2021 Mar-Apr

4.  Associations between conformity to masculine norms and depression: age effects from a population study of Australian men.

Authors:  Danielle Herreen; Simon Rice; Dianne Currier; Marisa Schlichthorst; Ian Zajac
Journal:  BMC Psychol       Date:  2021-02-19

5.  The effectiveness of a media-based intervention promoting help-seeking for mental health difficulties by Australian men: study protocol for a randomised controlled trial.

Authors:  Angela Nicholas; Simone Scotti Requena; Maria Ftanou; Simon Rice; Justine Fletcher; Andrew Mackinnon; Zac Seidler; Long Khanh-Dao Le; Cathrine Mihalopoulos; Jane Pirkis
Journal:  Trials       Date:  2022-04-11       Impact factor: 2.279

6.  The Gender Paradox: Understanding the Role of Masculinity in Suicidal Ideation.

Authors:  Laura Griffin; Warwick Hosking; Peter Richard Gill; Kim Shearson; Gavin Ivey; Jenny Sharples
Journal:  Am J Mens Health       Date:  2022 Sep-Oct

7.  Protocol for a cluster randomized control trial of the impact of the Breaking the Man Code workshops on adolescent boys' intentions to seek help.

Authors:  Kylie King; Marisa Schlichthorst; Patty Chondros; Simon Rice; Anna Clark; Long Khanh-Dao Le; Cathrine Mihalopoulos; Jane Pirkis
Journal:  Trials       Date:  2022-02-03       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.